Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 2101 - 2200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2101 | 26724275 |
US |
13 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2102 | 26724318 |
US |
62 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2103 | 26724337 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2104 | 26724340 |
US |
31 | 1 |
Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2105 | 26724347 |
US |
7 | 1 |
Dermatitis atopic, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 2106 | 26724350 |
US |
31 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2107 | 26724406 |
US |
11 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2108 | 26724428 |
US |
62 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2109 | 26724491 |
US |
54 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Stress, Dermatitis atopic, Dermatitis, Skin swelling, Skin exfoliation, Dry skin, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2110 | 26724498 |
US |
12 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2111 | 26724501 |
US |
50 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2112 | 26724505 |
US |
11 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2113 | 26724522 |
US |
80 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2114 | 26724531 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2115 | 26724532 |
US |
81 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 2116 | 26724535 |
US |
9 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2117 | 26724538 |
US |
41 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2118 | 26724584 |
US |
76 | 2 |
Dystonia, Systemic lupus erythematosus, Eczema, Injection site pain, Injection site haemorrhage, Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2119 | 26724588 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2120 | 26724596 |
US |
2 | |
Dermatitis atopic, Rash, Erythema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2121 | 26724600 |
US |
71 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 2122 | 26724612 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 2123 | 26724925 |
US |
24 | 2 |
Dermatitis atopic, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 2124 | 26724931 |
US |
55 | 2 |
Dermatitis atopic, Pruritus, Headache, Myalgia, Gait disturbance, Sleep disorder due to a general medical condition, Tendon pain, Loss of personal independence in daily activities, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 2125 | 26724942 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2126 | 26724952 |
US |
32 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2127 | 26724953 |
US |
8 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2128 | 26724954 |
US |
3 | 2 |
Dermatitis atopic, Dry skin, Skin exfoliation, Pruritus, Skin irritation, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 2129 | 26724957 |
US |
16 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2130 | 26724979 |
US |
35 | 2 |
Dermatitis atopic, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 2131 | 26725008 |
US |
24 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2132 | 26725183 |
US |
51 | |
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 2133 | 26725917 |
US |
60 | 1 |
Dermatitis atopic, Pruritus, Swelling, |
||||
DUPILUMAB, |
||||
| 2134 | 26725921 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2135 | 26725924 |
US |
48 | 2 |
Dermatitis atopic, Pruritus allergic, |
||||
DUPILUMAB, |
||||
| 2136 | 26725927 |
US |
3 | 1 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 2137 | 26725946 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2138 | 26726076 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2139 | 26726122 |
US |
4 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2140 | 26726125 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 2141 | 26726216 |
US |
2 | |
Dermatitis atopic, Rash erythematous, Rash, Skin exfoliation, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, LEBRIKIZUMAB-LBKZ, |
||||
| 2142 | 26726233 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2143 | 26726247 |
US |
29 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2144 | 26726255 |
US |
2 | 1 |
Dermatitis atopic, Illness, |
||||
DUPILUMAB, |
||||
| 2145 | 26726281 |
US |
49 | 2 |
Dermatitis atopic, Dry eye, Injection site pain, |
||||
DUPILUMAB, |
||||
| 2146 | 26726289 |
US |
64 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2147 | 26726386 |
US |
32 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2148 | 26726407 |
US |
50 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2149 | 26726412 |
US |
1 | |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, |
||||
| 2150 | 26726415 |
US |
35 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2151 | 26726432 |
US |
22 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2152 | 26726436 |
US |
64 | 1 |
Rash macular, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2153 | 26726474 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2154 | 26726493 |
US |
36 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2155 | 26726503 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2156 | 26726516 |
US |
2 | |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 2157 | 26726561 |
41 | 1 | |
Injection site pain, Dermatitis atopic, |
||||
TRALOKINUMAB-LDRM, |
||||
| 2158 | 26726591 |
US |
1 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 2159 | 26727239 |
US |
16 | 2 |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 2160 | 26729380 |
17 | 2 | |
Treatment noncompliance, Dermatitis atopic, Insurance issue, Product use issue, |
||||
TRALOKINUMAB-LDRM, ROFLUMILAST, LORATADINE, LORATADINE ORAL, MONTELUKAST, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 2161 | 26718794 |
US |
45 | 1 |
Sleep disorder, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, VENLAFAXINE HYDROCHLORIDE, MAGNESIUM OXIDE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 2162 | 26718805 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 2163 | 26718814 |
US |
2 | |
Pain, Skin burning sensation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2164 | 26718858 |
US |
47 | 2 |
Injection site pain, Injection site bruising, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 2165 | 26718924 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2166 | 26718953 |
US |
20 | 1 |
Discomfort, Dermatitis atopic, Intentional dose omission, Rash, |
||||
DUPILUMAB, |
||||
| 2167 | 26718994 |
US |
42 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2168 | 26719044 |
US |
2 | |
Dermatitis atopic, Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2169 | 26719051 |
US |
54 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OLMESARTAN MEDOXOMIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2170 | 26719054 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, CELECOXIB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ORAL SEMAGLUTIDE, PAROXETINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 2171 | 26719108 |
US |
68 | 2 |
Herpes zoster, Respiration abnormal, Sluggishness, Peripheral swelling, Headache, Neuralgia, Influenza, Gastrointestinal disorder, Dermatitis atopic, Therapeutic response unexpected, Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, QUERCETIN, QUERCETIN,, |
||||
| 2172 | 26719186 |
US |
12 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2173 | 26719190 |
US |
51 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2174 | 26719191 |
US |
53 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2175 | 26719201 |
US |
45 | 2 |
Dermatitis atopic, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 2176 | 26719393 |
US |
1 | |
Dermatitis atopic, Product storage error, |
||||
DUPILUMAB, |
||||
| 2177 | 26719396 |
US |
38 | 2 |
Dermatitis atopic, Rash, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 2178 | 26719421 |
US |
45 | 2 |
Dermatitis atopic, Rash, Skin irritation, |
||||
DUPILUMAB, |
||||
| 2179 | 26719452 |
US |
1 | |
Scab, Rash macular, Skin lesion, Psoriasis, Rash erythematous, Rash pruritic, Diarrhoea, Urticaria, Pruritus, Dry eye, Eye pruritus, Dermatitis atopic, Injection site pain, Product preparation issue, Drug ineffective, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, IRBESARTAN, FAMOTIDINE, TAMSULOSIN HYDROCHLORIDE, ORAL SEMAGLUTIDE, |
||||
| 2180 | 26719526 |
US |
2 | |
Arthropathy, Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, ACYCLOVIR, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, FENOFIBRATE, HYDROCHLOROTHIAZIDE, LISINOPRIL, INSULIN ASPART, PANTOPRAZOLE, TIZANIDINE, INSULIN DEGLUDEC, |
||||
| 2181 | 26719580 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2182 | 26719642 |
US |
42 | 1 |
Dermatitis atopic, Blister, Skin weeping, |
||||
DUPILUMAB, |
||||
| 2183 | 26719654 |
US |
2 | |
Eczema, Pruritus, Skin haemorrhage, Dermatitis atopic, Dry skin, Skin fissures, Insomnia, |
||||
DUPILUMAB, HYDROCHLOROTHIAZIDE, |
||||
| 2184 | 26719674 |
US |
76 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2185 | 26719807 |
US |
82 | |
Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 2186 | 26719869 |
US |
70 | 1 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 2187 | 26719876 |
US |
39 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, LEVONORGESTREL, |
||||
| 2188 | 26719882 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2189 | 26719892 |
US |
15 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2190 | 26719910 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2191 | 26719921 |
US |
3 | 1 |
Dermatitis atopic, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 2192 | 26719956 |
US |
4 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2193 | 26719957 |
US |
61 | 2 |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2194 | 26719970 |
US |
4 | 1 |
Dermatitis atopic, Skin lesion, |
||||
DUPILUMAB, |
||||
| 2195 | 26719971 |
US |
15 | 2 |
Photosensitivity reaction, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2196 | 26719972 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 2197 | 26719973 |
US |
45 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2198 | 26719974 |
US |
26 | 2 |
Dermatitis atopic, Seasonal allergy, Exfoliative rash, Rash erythematous, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 2199 | 26719986 |
US |
2 | |
Dermatitis atopic, Skin discomfort, Rash, |
||||
DUPILUMAB, AMLODIPINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PHENTERMINE HYDROCHLORIDE, |
||||
| 2200 | 26719987 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, ALPRAZOLAM, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE DIMESYLATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30